A clinical assay from Zeesan Biotech to detect and identify 14 high-risk genotypes of human papillomavirus has been approved by the China State Food and Drug Administration, company announced recently. The MeltPro High Risk HPV test, which w... Read More >

The global medical gas analyzers market was valued at USD 235 million in 2017 and is expected to grow at a CAGR of 4.1% from 2018 to 2025 to reach USD 325 million by 2025, driven by an upsurge in the adoption of medical gas analyzers, string... Read More >

BioMrieux reported today that its third quarter revenues grew 7 percent year over year driven in part by strong growth in its molecular biology clinical applications. For the three months ended Sept. 30, the Marcy ltoile, France-based in vit... Read More >

An estimated 100 million-plus people , roughly one-third of the U.S. population, will have had their DNA analyzed using an at-home genetic test kit by 2021. Up to 60% of the time, identified genetic variants are going to be proven correct wi... Read More >

When it comes toin vitrodiagnostic (IVD) technologies, medical device and diagnostic companies have been chomping at the bit to produce the next big innovation. The last few years have seen a surge in IVD technologies in the market, as devic... Read More >

CARLSBAD, MA, UNITED STATES - Oct 17, 2018 - Marking a milestone in bringing its Oncomine Dx Target Test toEurope,Thermo Fisher Scientifictoday announced that it has CE-IVD marked its next-generation sequencing (NGS)-based solution that scre... Read More >

Bacterial or viral infection, that is the question. Haifa-Israel based MeMed Diagnostics is developing a point-of-care platform and immune-based test that will one day be able to provide answers. Such a test could help with the overuse and u... Read More >

Patients living with autoimmune diseases such as rheumatoid arthritis, systemic lupus erythematosus (SLE), or multiple sclerosis must see their health practitioners frequently to check the progression of their conditions and their responses... Read More >

BGI has analyzed the worlds largest set of genome data from pregnant women, a total of 141,431 expectant mothers from across China. The results from the study were published inCell. The genomic analyses from non-invasive prenatal testing (NI... Read More >

After setting its sights on a $100 million IPO, CAR-T player Allogene Therapeutics has nearly tripled that, pricing the deal at the high end of the range and raising $288 million. Its stock price leaped as high as 39% on its first day of tra... Read More >